Results 11 to 20 of about 337,127 (342)

Tumor-infiltrating lymphocytes for melanoma immunotherapy

OncoImmunology, 2023
Oliver Kepp, Peng Liu, Laurence Zitvogel, Guido Kroemer   +3 more
doaj   +4 more sources

Tumor Infiltrating Lymphocytes in Different Stages of Malignant Melanoma and Correlation with Tumor Stage and Other Prognostic Factors: A Retrospective Multicenter Study [PDF]

Middle East Journal of Cancer, 2017
Background: Melanoma is one of the most immunogenic tumors that causes a significant immune response. Tumor infiltrating lymphocytes are an important part of this response. Tumor infiltrating lymphocytes are lymphocytes in close association with tumor
Alireza Ghanadan, Amir-Hoshang Ehsani, Ali-Mohammad Farahmand, Mojtaba Mirzaei   +3 more
doaj   +1 more source

Significance of tumor-associated neutrophils, lymphocytes, and neutrophil-to-lymphocyte ratio in non-invasive and invasive bladder urothelial carcinoma [PDF]

Journal of Pathology and Translational Medicine, 2023
Background Tumor-infiltrating neutrophils and lymphocytes play essential roles in promoting or combating various neoplasms. This study aimed to investigate the association between tumor-infiltrating neutrophils and lymphocytes and the neutrophil-to ...
Wael Abdo Hassan, Ahmed Kamal ElBanna, Noha Noufal, Mohamed El-Assmy, Hany Lotfy, Rehab Ibrahim Ali   +5 more
doaj   +1 more source

Dynamic roles of tumor-infiltrating B lymphocytes in cancer immunotherapy

Cancer Immunology, Immunotherapy
The amazing diversity of B cells within the tumor microenvironment is the basis for the diverse development of B cell-based immunotherapies. Here, we focus on elucidating the mechanisms of tumor intervention mediated by four tumor-infiltrating B ...
Shishengnan Song, Chong Wang, Yangchao Chen, Xiaorong Zhou, Yi Han, Haijian Zhang   +5 more
doaj   +2 more sources

Evaluation of tumor infiltrating lymphocytes in breast carcinomas

Journal of Pathology of Nepal, 2022
Background: Among the parameters that have a prognostic and/or predictive significance to therapeutic response, in the case of breast carcinoma, the study of tumor-infiltrating lymphocytes in breast carcinomas is emerging.
Shovana Karki, Sansar Babu Tiwari, Alina Basnet   +2 more
doaj   +1 more source

Tumor-Infiltrating Lymphocytes in Melanoma [PDF]

Current Oncology Reports, 2012
Adoptive cell therapy using tumor-infiltrating lymphocytes (TIL) is arguably the most effective treatment for patients with metastatic melanoma. With higher response rates than ipilimumab or IL-2, and longer durations of response than vemurafenib, TIL therapy carries the potential to transform current outcomes in melanoma, while also defining the way ...
Sylvia, Lee, Kim, Margolin
openaire   +2 more sources

Prognostic and Predictive Value of Immune-Related Gene Expression Signatures vs Tumor-Infiltrating Lymphocytes in Early-Stage ERBB2/HER2-Positive Breast Cancer

JAMA Oncology, 2023
Key Points Question Which immune-related biomarker provides the most valuable information to predict pathologic complete response and event-free survival in patients with early-stage ERBB2/HER2-positive breast cancer: tumor-infiltrating lymphocytes ...
A. Fernández-Martínez, T. Pascual, Baljit Singh, P. Nuciforo, N. Rashid, K. Ballman, J. Campbell, K. Hoadley, P. Spears, L. Paré, F. Brasó-Maristany, N. Chic, I. Krop, A. Partridge, J. Cortés, A. Llombart-Cussac, A. Prat, C. Perou, L. Carey   +18 more
semanticscholar   +1 more source

Tumor-Infiltrating Lymphocytes in Colorectal Cancer: The Fundamental Indication and Application on Immunotherapy

Frontiers in Immunology, 2022
The clinical success of immunotherapy has revolutionized the treatment of cancer patients, bringing renewed attention to tumor-infiltrating lymphocytes (TILs) of various cancer types.
Ziyi Bai, Yao Zhou, Zi-Dan Ye, Jialong Xiong, Hongying Lan, Feng Wang   +5 more
semanticscholar   +1 more source

Tumor-infiltrating lymphocytes in colorectal carcinoma

Journal of Pathology of Nepal, 2021
Background: Immunotherapy has become an important modality of treatment for CRC. The cells contributing to an effective immune response are CD8+ T cells of tumor-infiltrating lymphocytes.
Shovana Karki, Sanjib Pariyar
doaj   +1 more source

Artificial Intelligence–Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non–Small-Cell Lung Cancer

Journal of Clinical Oncology, 2022
PURPOSE Biomarkers on the basis of tumor-infiltrating lymphocytes (TIL) are potentially valuable in predicting the effectiveness of immune checkpoint inhibitors (ICI).
Sehhoon Park, C. Ock, Hyojin Kim, Sérgio Pereira, Seonwook Park, M. Ma, Sangjoon Choi, Seokhwi Kim, Seunghwan Shin, B. J. Aum, K. Paeng, Donggeun Yoo, H. Cha, Sunyoung Park, K. J. Suh, H. Jung, Se Hyun Kim, Y. J. Kim, Jong-Mu Sun, Jin-Haeng Chung, J. Ahn, M. Ahn, J. Lee, Keunchil Park, S. Song, Y. Bang, Yoon-La Choi, T. Mok, Se-Hoon Lee   +28 more
semanticscholar   +1 more source